2015
DOI: 10.1586/1744666x.2015.1008454
|View full text |Cite
|
Sign up to set email alerts
|

Genotyping in rheumatoid arthritis: a game changer in clinical management?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
5
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 21 publications
0
5
0
1
Order By: Relevance
“…Such molecular insights support a pivotal role for both CD4+ T cell and B cell lineages in the pathogenesis of RA (9)(10)(11). Mapping cellular mechanisms of genetic risk in the disease is far from straightforward, however, because lead single-nucleotide polymorphisms (SNPs) at associated loci are typically noncoding and intergenic, tagging linkage disequilibrium (LD) blocks that contain multiple genes (7,12).…”
mentioning
confidence: 99%
“…Such molecular insights support a pivotal role for both CD4+ T cell and B cell lineages in the pathogenesis of RA (9)(10)(11). Mapping cellular mechanisms of genetic risk in the disease is far from straightforward, however, because lead single-nucleotide polymorphisms (SNPs) at associated loci are typically noncoding and intergenic, tagging linkage disequilibrium (LD) blocks that contain multiple genes (7,12).…”
mentioning
confidence: 99%
“…Given that TCR only recognizes antigen peptides within HLA molecules on antigen-presenting cells, HLA molecules comprise a very important governing factor for autoimmunity. The HLA gene locus is highly polymorphic and represents the most investigated genetic factor related to RA [21][22][23]. In this context, special attention…”
Section: Introductionmentioning
confidence: 99%
“…Human leukocyte antigen (HLA) class II molecules are well-studied genetic factors closely associated with RA development (5). However, the contribution of the HLA is considered to only account for 30% of the total genetic factors of susceptibility (6). Thus, it is critical to identify novel biomarkers responsible for RA susceptibility.…”
Section: Introductionmentioning
confidence: 99%